Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Six-transmembrane epithelial antigen of prostate 2 (STEAP2) is a member of the STEAP family, functioning primarily as a metalloreductase involved in metal ion reduction and transport. It is overexpressed in various cancers, particularly prostate cancer, contributing to tumor progression through effects on cell proliferation, migration, apoptosis resistance, and therapeutic resistance. It also plays a role in modulating inflammation and is involved in several metabolic pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Six-Transmembrane Epithelial Antigen of Prostate 2 (STEAP2).